Committed to the future of health in Asia

APFID is a non-profit foundation established to address the urgent need for international cooperation to control and prevent infectious diseases, which remain the leading cause of death worldwide. The Foundation focuses on the Asia-Pacific region, where the threat of antimicrobial resistance is most critical, and supports research programs such as the Asian Network for Surveillance of Resistant Pathogens (ANSORP), the Asian Bacterial Bank (ABB), and the Infectious Disease Research Institute (IDRI). APFID also organizes the biennial International Symposium on Antimicrobial Agents and Resistance (ISAAR) to facilitate scientific exchange and collaboration on infectious diseases and antimicrobial resistance. In addition to research, APFID has launched the international campaign "STOP, Superbug", which promotes public awareness of the appropriate use of antibiotics and aims to control antimicrobial resistance in the Asia-Pacific region. By collaborating with various institutions, organizations, industries and scientific societies, APFID aims to contribute to the improvement of public health not only in the Asia-Pacific region but globally.

For more information, please visit www.apfid.org

Contribute to the pivotal exchange of state-of-the-art information and data

ISAAR is a major global conference with a strong focus on antimicrobial resistance, antimicrobial treatment, new antimicrobial agents and vaccines, and future strategies against infectious diseases. It has become the most representative international event on antimicrobial resistance and infectious diseases in the Asia-Pacific region. The conference aims to facilitate the exchange of state-of-the-art information and data on infectious diseases and antimicrobial resistance worldwide, covering key topics such as epidemiology, resistance mechanisms, pathogenesis, clinical impact, new drug development, and prevention and treatment guidelines. This cutting-edge information can help promote global solutions to the challenge of infectious diseases and antimicrobial resistance. ISAAR is truly the world's premier congress on antimicrobial agents, resistance and major infectious disease issues.

Founded in 1958, the Korean Society for Antimicrobial Therapy (KSAT) has remained dedicated to guiding and promoting the appropriate use of antibiotics in Korea. As antibiotic resistance becomes an increasingly pressing issue, KSAT has set several key goals to combat this problem. These goals include intensifying efforts to develop and disseminate guidelines for the appropriate use of antibiotics, institutionalizing antibiotic stewardship, providing education on the appropriate use of antibiotics, and considering KSAT's role in the treatment and prevention of emerging infectious diseases. With the support of its members, KSAT is committed to fighting antibiotic resistance, protecting public health, and proactively contributing to public health crises. The Society is also working to revitalize academic exchanges affected by the COVID-19 pandemic and to promote effective communication among all stakeholders.

For more information, please visit www.ksat.or.kr/eng/